The UK Supreme Court overturned the decision of the High Court and the Court of Appeal that HGS’s patent directed towards Neutrokine, a new protein and member of the ligand superfamily, lacked industrial applicability.

Click here for the full text of this case. A summary of this case will be posted on


To make sure you do not miss out on regular updates from the Kluwer Patent Blog, please subscribe here.

Kluwer IP Law